NDUFAF7 is located on the p arm of chromosome 2 in position 22.2 and has 14 exons.[1] The NDUFAF7 gene produces a 49.2 kDa protein composed of 441 amino acids.[5][6] NDUFAF7 is believed to be a part of the S-adenosylmethionine-dependent methyltransferase family. This family has a characteristic seven-β-strand protein fold. NDUFAF7 is a type II arginine methyltransferase, meaning that its enzymatic activity produces a symmetrical ω-NG,NG′-dimethylarginine.[7] It has a methyltransferase domain and an N-terminal sequence that corresponds to the recognized mitochondrial-targeting peptide.[8] NDUFAF7's stoichometry is disputed with some findings indicating that it is a homodimer,[8] while others denote it to be monomeric.[9][2]
Function
The NDUFAF7 gene encodes an assembly factor protein that is localized in the mitochondria and which helps in the assembly and stabilization of complex I, a large multi-subunit enzyme in the mitochondrial respiratory chain.[1][8] NADH:ubiquinone oxidoreductase (complex I) is involved in several physiological activities in the cell, including metabolite transport and ATP synthesis. Complex I catalyzes the transfer of electrons from NADH to ubiquinone (coenzyme Q) in the first step of the mitochondrial respiratory chain, resulting in the translocation of protons across the inner mitochondrial membrane.[10] The encoded protein of NDUFAF7 is a methyltransferase that symmetrically dimethylates the ω-NG,NG′ atoms of Arg85 of subunit NDUFS2 of complex I in the early stages of its assembly. This interaction between NDUFAF7 and NDUFS2 is believed to be transient and it is suggested that this methylation stabilizes a 400 kDa subcomplex primarily associated with the peripheral arm of complex I. Without this methylation, the amount of intact complex I is significantly reduced, illustrating NDUFAF7's importance to the mitochondrial respiratory chain. A pseudogene related to this gene is located on chromosome 8. Alternative splicing results in multiple transcript variants.[1][7]
Clinical significance
Defects in NDUFAF7 may be a cause of susceptibility to pathologic myopia, a genetically heterogeneous disorder characterized by extreme, familial, early-onset vision loss and described as myopia accompanied by severe deformation of the eye besides excessive elongation of the eye. This defect, a heterozygous D266E missense mutation, also resulted in reduced complex I activity.[2][4] Due to is role in early assembly of complex I, it has been suggested that mutations affecting NDUFAF7 may be lethal.[7]
Interactions
NDUFAF7 interacts transiently with NDUFS2, dimethylating Arg85 on the subunit.[7] A correlation between the presence of MidA and NDUFS7 was also identified.[8] In addition to co-complexes, NDUFAF4 has protein-protein interactions with LRRK2, q5nfq6_fratt, and q5ngw2_fratt.[11]
↑Donald Voet; Judith G. Voet; Charlotte W. Pratt (2013). "18". Fundamentals of biochemistry : life at the molecular level (4th ed.). Hoboken, NJ: Wiley. pp. 581–620. ISBN9780470547847.
↑ 4.04.1Wang B, Liu Y, Chen S, Wu Y, Lin S, Duan Y, Zheng K, Zhang L, Gu X, Hong W, Shao H, Zeng X, Sun B, Duan S (August 2017). "A Novel Potentially Causative Variant of NDUFAF7 Revealed by Mutation Screening in a Chinese Family With Pathologic Myopia". Investigative Ophthalmology & Visual Science. 58 (10): 4182–4192. doi:10.1167/iovs.16-20941. PMID28837730.
↑ 8.08.18.28.3Carilla-Latorre S, Gallardo ME, Annesley SJ, Calvo-Garrido J, Graña O, Accari SL, Smith PK, Valencia A, Garesse R, Fisher PR, Escalante R (May 2010). "MidA is a putative methyltransferase that is required for mitochondrial complex I function". Journal of Cell Science. 123 (Pt 10): 1674–83. doi:10.1242/jcs.066076. PMID20406883.
